DEPLOY

Consumer model

Whoop (5.0 / MG)

By Whoop · biometric

Price
—
Availability
Shipping now.
Maturity
commercial
Real-world use
No verified deployments

Whoop (the 5.0 and the 'Medical Grade' MG, both launched May 8, 2025, from Whoop, founded 2012 in Boston by Will Ahmed) is a screen-free biometric wrist band and the subscription-only archetype of the biometric cohort: there is no standalone hardware sale. Access is a membership, Whoop One at $199/year, Peak at $239/year, and Life at $359/year (which includes the MG hardware), with the band provided inside the subscription. Its PPG, skin-temperature, SpO2, and respiratory sensors feed Strain, Recovery, and Sleep Coach analytics and an LLM 'Whoop Coach'; the MG adds ECG, Blood Pressure Insights, and a Healthspan / 'Whoop Age' feature. DEPLOY records commercial maturity and a reported $10.1 billion valuation (March 2026). Whoop is the strongest verified-vs-claimed cautionary exemplar in the cohort: its ECG is FDA-cleared (2025), but it marketed Blood Pressure Insights without clearance, drew an FDA Warning Letter on July 14, 2025, refused to remove the feature, and as of May 2026 the matter is unresolved with a class action filed, the market-first contrast to Oura's study-first posture.

Readiness

Whoop (5.0 / MG) is shipping now, no capability claims are on file, the model has no verified field deployments in the registry, and 3 incidents are on record.

Availability
shipping-now

Shipping now.

see evidence →

Price honesty
no-price

No price points on file for Whoop (5.0 / MG).

see evidence →

Capability honesty
no-claims

No reviewed capability claims on file for Whoop (5.0 / MG).

see evidence →

Real-world use
commercial

Maturity: commercial. No verified deployments in the registry.

see evidence →

Safety record
incidents-on-file

3 incidents on record across 0 verified deployments.

see evidence →

What it claims to do

No reviewed capability claims on file.

Price

No reviewed price points on file.

Real-world use

No verified deployments on file for Whoop (5.0 / MG).

Safety record

Privacy

No privacy practices disclosed or on file for Whoop (5.0 / MG).

Specs

notes
[{"label":"THE verified-vs-claimed exemplar (the ECG-vs-BP split)","value":"ECG IS FDA-cleared: 510(k) K243236, cleared Apr 4 2025 (OTC ECG on Whoop MG; classifies AFib/sinus/low-HR/high-HR; 22+). Blood Pressure Insights is NOT cleared and is the load-bearing marketing-beyond-clearance case: FDA WARNING LETTER to WHOOP Inc dated Jul 14 2025 (CMS #709755) - FDA held that daily systolic/diastolic estimates are 'inherently associated with the diagnosis of' hypertension/hypotension, meeting the device definition + requiring premarket clearance Whoop never obtained ('An erroneously low or high blood pressure reading can have significant consequences')."},{"label":"Status + Whoop's contested defense","value":"Whoop argues BPI is a 'general wellness' feature under the 21st Century Cures Act and REFUSED to remove it; the FDA compliance deadline passed. As of May 21 2026 the dispute is UNRESOLVED (Whoop + FDA in discussions; BPI remains LIVE on the MG); the warning letter now anchors a class-action lawsuit. 'Medical-grade' branding applies defensibly only to the cleared ECG, not to BP."},{"label":"CORRECTION (valuation)","value":"Valuation is $10.1B (Series G $575M, Mar 2026; QIA/Mubadala) - NOT the stale ~$3.6B (that was the Aug 2021 Series F)."},{"label":"Verification posture","value":"Boundary: biometric-primary + AI-augmented (subscription model bundles the device). Clinical posture: MIXED/CONTESTED - ECG has a real 510(k) + study, but the BP warning letter is a public regulatory finding of marketing a diagnostic-grade metric without validation. NOT verified / disputed: BPI accuracy + its 'general wellness' classification (FDA rejects); 'Healthspan/Whoop Age' (proprietary longevity construct, no clinical validation); Strain/Recovery (proprietary, uncleared)."},{"label":"Re-verify 2026-06-03","value":"FDA warning-letter / Blood Pressure Insights (BPI) dispute CONFIRMED-CURRENT: still UNRESOLVED as of late May 2026 (Whoop + FDA in discussions, BPI remains live, no enforcement escalation, no recall). Class action Rowe v. WHOOP No. 3:25-cv-09910 (N.D. Cal., filed Nov 18 2025) still early/unadjudicated. CORRECTION: the $575M Series G (Mar 31 2026, $10.1B valuation) was LED by Collaborative Fund; QIA, Mubadala, Abbott, and Mayo Clinic PARTICIPATED (supersedes the earlier 'QIA/Mubadala led' attribution). Context (reported-only, primary doc not retrieved): an FDA Jan 6 2026 general-wellness guidance update reportedly bears on the BPI 'wellness' argument."}]
specs
Whoop 5.0 + Whoop MG ('Medical Grade'), both May 8 2025 (replaced 4.0); ~14-day battery. Sensors: PPG optical HR/HRV, skin temp, SpO2, respiratory rate. Analytics: Strain, Recovery, Sleep Coach; MG adds ECG + Blood Pressure Insights + Healthspan/'Whoop Age'. AI 'Whoop Coach' (LLM). Founded 2012, Boston (Will Ahmed). SUBSCRIPTION-ONLY: Whoop One $199/yr, Peak $239/yr, Life $359/yr (MG) - no standalone hardware sale.
formFactor
biometric (biometric-primary screen-free wrist band; subscription-only; strain/recovery AI)

What's under the hood

No brain on file for Whoop (5.0 / MG).

Frequently asked questions

Is the Whoop (5.0 / MG) actually available for purchase?
Yes, shipping now.Source: FDA Warning Letter to WHOOP Inc (Jul 14 2025): Blood Pressure Insights marketed without clearance
What does the Whoop (5.0 / MG) cost?
Not announced.
Where is the Whoop (5.0 / MG) being used?
No verified field deployments on record.
Is the Whoop (5.0 / MG) safe?
Incidents on record: 3 (2 other, 1 regulatory_action). See Class action (Rowe v. WHOOP) alleges WHOOP falsely advertised BPI as medical-grade.Source: Class action (Rowe v. WHOOP) alleges WHOOP falsely advertised BPI as medical-grade
How does the Whoop (5.0 / MG) handle privacy?
No privacy practices disclosed or on file for Whoop (5.0 / MG).
Who makes the Whoop (5.0 / MG)?
Whoop (5.0 / MG) is made by Whoop, based in Boston, Massachusetts, USA.Source: FDA Warning Letter to WHOOP Inc (Jul 14 2025): Blood Pressure Insights marketed without clearance

Video

PRIMARY SOURCE
Courtesy of Whoop

WHOOP's introduction of its latest wearable experience. The WHOOP MG includes an FDA-cleared ECG; Strain, Recovery, and Sleep are wellness-grade proprietary scores.

Manufacturer

Whoop (registry record: /companies/whoop)

Compared to

Sources

  1. FDA Warning Letter to WHOOP Inc (Jul 14 2025): Blood Pressure Insights marketed without clearance · https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/whoop-inc-709755-07142025
  2. Whoop MG ECG FDA 510(k) K243236 (cleared Apr 4 2025; OTC ECG, AFib/sinus/low-HR/high-HR) · https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K243236
  3. Whoop-FDA blood-pressure dispute unresolved (May 2026); BPI remains live; class action · https://www.statnews.com/2026/05/21/whoop-fda-blood-pressure-dispute-unresolved/
  4. Whoop raises $575M Series G at $10.1B valuation (Mar 2026) · https://techcrunch.com/2026/03/31/whoop-raises-575m-series-g-10-billion-valuation/
  5. Whoop and FDA still in discussions over Blood Pressure feature; dispute unresolved (May 21 2026) · https://www.statnews.com/2026/05/21/whoop-has-not-resolved-fda-dispute-over-blood-pressure-feature/
  6. FDA warning letter anchors class action Rowe v. WHOOP No. 3:25-cv-09910 (N.D. Cal., filed Nov 18 2025; early stage) · https://www.afslaw.com/perspectives/longevity-lens/whoop-there-it-fda-warning-letter-now-anchors-class-action-against
  7. Whoop official YouTube (@WHOOP), embedded under standard YouTube embed terms. oEmbed author_url verified 2026-06-04. Maker product video. · https://www.youtube.com/watch?v=rZm8VHPkPoI · 2026-06-04

Machine-readable: this page as markdown.

Canonical: https://deploy.report/models/whoop-mg